KeyGene, Genalice Ink Licensing Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Plant genomics firm KeyGene and startup bioinformatics company Genalice today announced a deal aimed at improving plant DNA analysis.

As part of the agreement, KeyGene will license Genalice MAP, a short-read alignment tool, which processes raw next-generation sequencing data into a small and easily manageable file for low-cost storage or further analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.